Cytomegalovirus colitis in a patient treated with efalizumab.
Caudron
Anne
A
Lok
Catherine
C
Clabaut
Angèle
A
Desblache
Julien
J
Heyman
Bertrand
B
Viseux
Valérie
V
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D003092:Colitis / Q000276:immunology / Q000821:virology*; D003586:Cytomegalovirus Infections / Q000150:complications*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C472181:efalizumab